Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Sigmoid Neoplasms 1Erectile Dysfunction 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 225Leucovorin 209Irinotecan 151Radiotherapy 132Bevacizumab 112Cetuximab 81Folfox protocol 49Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × udenafil × Clear all
NCT01421940 2015-03-10

The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer

Kyungpook National University Hospital

Phase 4 Completed
80 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00607282 2012-09-05

Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer

Seoul National University Hospital

Phase 2 Completed
46 enrolled
Gastrointestinal

Erectile Dysfunction, Rectal Neoplasms, Sigmoid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡